Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study
Abstract Background Immunotherapy has been administered to many patients with non-small-cell lung cancer (NSCLC). However, only few studies have examined toxicity in patients receiving an immune checkpoint inhibitor (ICI) after concurrent chemoradiotherapy (CCRT). Therefore, we performed a retrospec...
Enregistré dans:
Auteurs principaux: | Jeong Yun Jang, Su Ssan Kim, Si Yeol Song, Yeon Joo Kim, Sung-woo Kim, Eun Kyung Choi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/733581fe7b7140b29f334aa68bcd9aaf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The role of haematological parameters in predicting the response to radical chemoradiotherapy in patients with anal squamous cell cancer
par: Stojanovic-Rundic Suzana, et autres
Publié: (2021) -
Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up
par: Lei Wang, et autres
Publié: (2021) -
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
par: Jaehyeon Park, et autres
Publié: (2021) -
Clinical outcomes in stage III non-small cell lung cancer patients treated with durvalumab after sequential or concurrent platinum-based chemoradiotherapy – single institute experience
par: Vrankar Martina, et autres
Publié: (2021) -
Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients
par: Chanon Puttanawarut, et autres
Publié: (2021)